enGene Holdings Inc.

Nasdaq:ENGNNasdaq:ENGNW

Biological Products, (No Diagnostic Substances)·SAINT-LAURENT, A8

Financials

11 shown

Type	Period	Ended	Filed
10-K/A	FY 2025	10/31/25	2/19/26	→
10-K	FY 2025	10/31/25	12/22/25	→
10-Q	Q3 2025	7/31/25	9/11/25	→
10-Q	Q2 2025	4/30/25	6/12/25	→
10-Q	Q1 2025	1/31/25	3/10/25	→
10-K/A	FY 2024	10/31/24	2/20/25	→
↓

Earnings Releases (8-K)

9 shown

Filed	Period
12/22/25	Q1 FY2026	→
9/11/25	Q4 FY2025	→
6/12/25	Q3 FY2025	→
3/10/25	Q2 FY2025	→
12/19/24	Q1 FY2025	→
9/10/24	Q4 FY2024	→
↓

News (8-K)

26 shown

Filed	Type	Description
1/21/26	Agreement	Entry into a Material Definitive Agreement	→
1/21/26	Reg FD	Regulation FD Disclosure	→
11/14/25	Agreement	Entry into a Material Definitive Agreement	→
11/12/25	Reg FD	Regulation FD Disclosure	→
10/2/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
10/2/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
↓

Prospectuses & Registrations

30 shown

Filed	Form	Description
2/19/26	S-3	S-3	→
11/14/25	424B5	424B5	→
11/12/25	424B5	424B5	→
9/11/25	S-8	S-8	→
5/9/25	ARS	ARS	→
3/10/25	S-8	S-8	→
↓

Filing History(226 filings)

TypeDateAccessionPeriodSize

EFFECT

Mar 2, 2026

9999999995-26-000700

—

1.7 KB

S-3

Feb 19, 2026

0001193125-26-059479S-3

—

2.0 MB

10-K/A

Feb 19, 2026

0001193125-26-05940910-K/A

Oct 31, 2025

1.2 MB

SCHEDULE 13G/A

Feb 17, 2026

0001738048-26-000020

—

17.3 KB

SCHEDULE 13G

Feb 17, 2026

0001172661-26-001032

—

10.4 KB

SCHEDULE 13G/A

Feb 17, 2026

0001907884-26-000003

—

9.2 KB

Feb 3, 2026

0000929638-26-000484

Jan 30, 2026

4.9 KB

Feb 3, 2026

0000929638-26-000483

Jan 30, 2026

4.9 KB

Feb 3, 2026

0000929638-26-000482

Jan 30, 2026

4.9 KB

Feb 3, 2026

0000929638-26-000481

Jan 30, 2026

4.9 KB

Feb 3, 2026

0000929638-26-000480

Jan 30, 2026

5.1 KB

Feb 3, 2026

0000929638-26-000479

Jan 30, 2026

5.0 KB

Feb 3, 2026

0000929638-26-000478

Jan 30, 2026

4.9 KB

Feb 3, 2026

0000929638-26-000477

Jan 30, 2026

5.0 KB

SCHEDULE 13G

Jan 27, 2026

0002005369-26-000002

—

24.4 KB

8-K

Jan 21, 2026

0001193125-26-0179458-K

Jan 20, 2026

1.4 MB

8-K

Jan 21, 2026

0001193125-26-0172268-K

Jan 20, 2026

244.4 KB

10-K

Dec 22, 2025

0001193125-25-32874310-K

Oct 31, 2025

16.3 MB

8-K

Dec 22, 2025

0001193125-25-3287068-K

Dec 22, 2025

351.4 KB

SCHEDULE 13G

Nov 18, 2025

0001172661-25-005207

—

10.9 KB

SCHEDULE 13G

Nov 18, 2025

0001193125-25-286126

—

172.0 KB

8-K

Nov 14, 2025

0001193125-25-2831828-K

Nov 12, 2025

712.3 KB

SCHEDULE 13G/A

Nov 14, 2025

0001172661-25-004824

—

11.1 KB

424B5

Nov 14, 2025

0001193125-25-281504424B5

—

628.8 KB

424B5

Nov 12, 2025

0001193125-25-277833424B5

—

589.0 KB

25 filings shown

enGene Holdings Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(226 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
5/9/25	DEF 14A	2025 PROXY STATEMENTS	→
4/18/24	DEF 14A	DEF 14A	→

Filed	Form	Description
2/3/26	4	4	→
2/3/26	4	4	→
2/3/26	4	4	→
2/3/26	4	4	→
2/3/26	4	4	→
2/3/26	4	4	→
↓

Filed	Form	Description
3/2/26	EFFECT	EFFECT	→
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/17/26	SCHEDULE 13G	SCHEDULE 13G	→
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
1/27/26	SCHEDULE 13G	SCHEDULE 13G	→
11/18/25	SCHEDULE 13G	SCHEDULE 13G	→
↓